About MBL
MBL provides high-quality products & solutions to advance life science research
MBL is committed to being a leading manufacturer and supplier of diagnostic reagents that facilitate further advances in personalized medicine and individualization of medical care and responding to strong medico-social needs such as quick and accurate infectious disease diagnosis.
With over 400 worldwide employees and 6 facilities in Japan and China, MBL was founded as Japan’s first antibody manufacturing company in 1969 to continuously take on the innovative diagnostic technology for each life. In 1970s, MBL initiated the development of diagnostic pharmaceuticals for autoimmune diseases as a leader of the companies of such products in Japan.
Furthermore, we launched the distribution of a companion diagnostic (CDx) for the first time in Japan, followed by business evolution that included the development of genetic diagnostic services.
We will contribute to people’s health and medical development using our innovative diagnostic technology to meet consistent challenges.
.png?width=248&height=105&name=MBL%20logomark%20RGB%20color_transparent%20background_blue%20text%2001%20(1).png)
MBL Offerings
MBL operates all processes required for manufacturing in vitro diagnostics products, from R&D to clinical performance study, to regulatory authorization application, to manufacturing and marketing. This system builds a close and trusted partnership with KOL physicians and achieves speedy commercialization.
MBL CAN HELP
